Sort
30,917 grants matching “tumor microenvironment”
Extracellular Vesicles (EVs) and Genes in the Biology and Therapy of Gliomas
$1,316,276Xandra Owens Breakefield · Massachusetts General Hospital · P01 · FY2020 · CA
Extracellular Vesicles (EVs) and Genes in the Biology and Therapy of Gliomas
$1,316,194Xandra Owens Breakefield · Massachusetts General Hospital · P01 · FY2021 · CA
Molecular Mechanisms Regulating Mouse Mammary Gland and Human Breast Tumor Cells
$1,313,218Gisela Sterneck · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
HORMAD-specific TGF-beta resistant memory T cells for treatment of patients with Gastro-esophageal Cancer
$1,310,673Cassian Yee · University Of Tx Md Anderson Can Ctr · UG3 · FY2024 · CA
Role of the microbiota in regulating the mononuclear phagocyte system
$1,310,229Silvana Goldszmid · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
The Role of the Microenvironment in Barrett's Esophagus
$1,310,083Timothy Cragin Wang · Columbia University Health Sciences · U54 · FY2017 · CA
Nanotechnology Linking Biomarkers with Cancer Behavior
$1,309,745Shuming Nie · Emory University · R01 · FY2008 · CA
Development of a novel therapy targeting the tumor microenvironment in inflammatory breast cancer
$1,309,379Naoto T Ueno · University Of Hawaii At Manoa · R01 · FY2025 · CA
Center for Multiparametric Imaging of Tumor Immune Microenvironments
$1,309,112Paolo Provenzano · University Of Minnesota · U54 · FY2022 · CA
Architecture and Trajectory of Acquired Resistance to Therapy in AML
$1,308,998Jeffrey Wallace Tyner · Oregon Health & Science University · U54 · FY2023 · CA
Architecture and Trajectory of Acquired Resistance to Therapy in AML
$1,308,998Jeffrey Wallace Tyner · Oregon Health & Science University · U54 · FY2022 · CA
Architecture and Trajectory of Acquired Resistance to Therapy in AML
$1,308,996Jeffrey Wallace Tyner · Oregon Health & Science University · U54 · FY2025 · CA
Cancer Prevention-Interception Against MGUS Progression
$1,308,925Yong Li · Baylor College Of Medicine · U54 · FY2025 · CA
Role of the microbiota in regulating the mononuclear phagocyte system
$1,307,792Romina Goldszmid · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Human Melanoma - Etiology, Progression and Therapy
$1,306,113Meenhard Herlyn · Wistar Institute · P01 · FY2007 · CA
Unraveling the Molecular Underpinnings of Premalignant Oral Lesion Transformation into Head and Neck Cancer
$1,305,876Joe Nguyen · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
Lymphomas And Retroviral Pathogenesis
$1,305,511Herbert C Morse · Niaid Extramural Activities · Z01 · FY2007 · AI
Next generation T cell therapies for mutant KRAS solid tumors
$1,305,260Beatriz M. Carreno · University Of Pennsylvania · UG3 · FY2023 · CA
Modulation of cancer induced immune suppression via inhibition of SCD1
$1,301,808Karen E Hayes · Modulation Therapeutics, Inc. · R44 · FY2023 · CA
Leveraging DNA damage repair pathways as therapeutic targets in womens cancers
$1,301,281Jung-Min Lee · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Investigating mechanisms of bladder tumorigenesis and therapeutic resistance
$1,300,700Abdul Banday · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
Phase I clinical trial of adoptive transfer of autologous folate receptor-alpha redirected CAR T cells for ovarian cancer
$1,300,301Daniel J. Powell · University Of Pennsylvania · R01 · FY2025 · CA
Stem Cell Toxicology
$1,297,973Erik Tokar · National Institute Of Environmental Health Sciences · ZIA · FY2017 · ES
Human Melanoma - Etiology, Progression and Therapy
$1,297,419Meenhard Herlyn · Wistar Institute · P01 · FY2006 · CA
Perivascular plasticity in metastatic microenvironments
$1,295,670Meera Murgai · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA